Affymetrix, Inc. (Nasdaq:AFFX) today announced that company management will provide a corporate overview at four upcoming financial conferences in May.

John Batty, Executive Vice President and CFO, will present at the following conferences:

  • Morgan Stanley Global Healthcare Conference in Key Biscayne, FL on May 1, 2008 at 11:20 am ET
  • Deutsche Bank Health Care Conference in Boston on May 5, 2008 at 4:40 pm ET
  • Baird Growth Stock Conference in Chicago on May 14, 2008 at 7:45 am CT
  • NASDAQ Investor Program on May 21, 2008 at 9:30 am UK time

Live webcasts of all presentations will be available at under the “Investors” link in the “Resources for” drop-down menu. Archived webcasts will be available for 30 days.

About Affymetrix

Affymetrix GeneChip® microarray technology is the industry-standard tool for analyzing complex genetic information. After inventing microarray technology in the late 1980s, Affymetrix scientists have been dedicated to developing innovative products that provide researchers with a more complete view of the genome. These products continue to accelerate genetic research and enable scientists to develop diagnostics and tailor treatments for individual patients by identifying and measuring the genetic information associated with complex diseases.

Today, Affymetrix technology is used by the world’s top pharmaceutical, diagnostic and biotechnology companies, as well as leading academic, government and not-for-profit research institutes. More than 1,700 systems have been shipped around the world and more than 12,000 peer-reviewed papers have been published using the technology.

Affymetrix is headquartered in Santa Clara, Calif., and has manufacturing facilities in Sacramento, Calif., Cleveland, Ohio and Singapore. The company has about 1,100 employees worldwide and maintains sales and distribution operations across Europe and Asia. For more information about Affymetrix, please visit:

NOTE: Affymetrix, the Affymetrix logo and GeneChip(R) are registered trademarks owned or used by Affymetrix Inc.